Search for other papers by Xian Qiu in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China
Search for other papers by Ri Sa in
Google Scholar
PubMed
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Hao Fu in
Google Scholar
PubMed
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
, thyroglobulin (Tg), and anti-Tg antibody (TgAb) were measured by electrochemiluminescence immunoassay on a Cobas analyzer (Roche Diagnostics Gmbh, Roche Ltd.). Safety and tolerability were monitored simultaneously. The severity of AEs was graded according to the
Search for other papers by Tetsuya Mizokami in
Google Scholar
PubMed
Department of Medicine, Kuma Hospital, Kobe
Search for other papers by Shuji Fukata in
Google Scholar
PubMed
Search for other papers by Akira Hishinuma in
Google Scholar
PubMed
Search for other papers by Takahiko Kogai in
Google Scholar
PubMed
Search for other papers by Katsuhiko Hamada in
Google Scholar
PubMed
Search for other papers by Tetsushi Maruta in
Google Scholar
PubMed
Search for other papers by Kiichiro Higashi in
Google Scholar
PubMed
Search for other papers by Junichi Tajiri in
Google Scholar
PubMed
peroxidase and antithyroglobulin antibodies were negative. The serum thyroglobulin level was 82.8 ng/ml. Neither the thyroid nor the salivary glands were visualized by 99m TcO 4 - scintigraphy. We genetically tested for the NIS gene mutation with her
Search for other papers by Giovanni de Gennaro in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Michele Marinò in
Google Scholar
PubMed
.7–5.7 pg/mL), and an FT4 of 0.96 ng/dL (normal range 0.7–1.7 ng/dL). The concentration of anti-thyroperoxidase antibody (TPOAb) was > 1,000 IU/mL (normal range ≤10 IU/mL) and that of anti-thyroglobulin antibody (TgAb) was 755 IU/mL (normal value ≤30 IU
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Ayanthi Wijewardene in
Google Scholar
PubMed
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Matti Gild in
Google Scholar
PubMed
Search for other papers by Carolina Nylén in
Google Scholar
PubMed
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia
Search for other papers by Geoffrey Schembri in
Google Scholar
PubMed
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia
Search for other papers by Paul Roach in
Google Scholar
PubMed
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia
Search for other papers by Jeremy Hoang in
Google Scholar
PubMed
Search for other papers by Ahmad Aniss in
Google Scholar
PubMed
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia
Search for other papers by Anthony Glover in
Google Scholar
PubMed
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia
Search for other papers by Mark Sywak in
Google Scholar
PubMed
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia
Search for other papers by Stan Sidhu in
Google Scholar
PubMed
Search for other papers by Diana Learoyd in
Google Scholar
PubMed
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Bruce Robinson in
Google Scholar
PubMed
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Lyndal Tacon in
Google Scholar
PubMed
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed
-thyroidal extension, and/or venous invasion, and/or lymph node involvement <3 cm, and/or >5 involved lymph nodes [ 5 ]. In addition, tumour size >4 cm and/or post-operative thyroglobulin (Tg) >10 ng/L may be associated with increased risk of recurrence, although
Search for other papers by Yasmine Abdellaoui in
Google Scholar
PubMed
Search for other papers by Dimitra Magkou in
Google Scholar
PubMed
Search for other papers by Sofia Bakopoulou in
Google Scholar
PubMed
Search for other papers by Ramona Zaharia in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Marie-Laure Raffin-Sanson in
Google Scholar
PubMed
EA 4340, Université Versailles Saint Quentin en Yvelines, UFR Simone Veil Santé, Montigny le Bretonneux, France
Search for other papers by Laure Cazabat in
Google Scholar
PubMed
tested for thyroid function. THRB , thyroid hormone receptor beta; FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyrotropin; TG, thyroglobulin; TPO, thyroperoxidase; Ab, autoantibodies; TRAb, TSH receptor antibodies; wt, wild-type sequence; N
Search for other papers by Pedro Marques in
Google Scholar
PubMed
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Maria João Bugalho in
Google Scholar
PubMed
-level stratification proposed by the American Thyroid Association was used [ 2 ]. Follow-up was based mainly on TSH-suppressed thyroglobulin and cervical US. Response to initial therapy was defined as NED (no evidence of disease - suppressed thyroglobulin <1 ng
Search for other papers by Kaoru Kobayashi in
Google Scholar
PubMed
Search for other papers by Hisashi Ota in
Google Scholar
PubMed
Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Search for other papers by Tomonori Yabuta in
Google Scholar
PubMed
Search for other papers by Mitsuhiro Fukushima in
Google Scholar
PubMed
Search for other papers by Hiroo Masuoka in
Google Scholar
PubMed
Search for other papers by Takuya Higashiyama in
Google Scholar
PubMed
Search for other papers by Minoru Kihara in
Google Scholar
PubMed
Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Search for other papers by Akihiro Miya in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
-Old Woman The serum study revealed: free T4 1.10 ng/dL (reference range 0.70-1.60), free T3 3.27 pg/mL (1.70-3.70), thyroglobulin 942.4 ng/mL (<35), and TgAb <28.0 (<39.9). The nodule in the right lobe presented with a “nodule in nodule” appearance on
University of Lille, Lille, France
Search for other papers by Hippolyte Dupuis in
Google Scholar
PubMed
Search for other papers by Emilie Merlen in
Google Scholar
PubMed
University of Lille, Lille, France
Search for other papers by Arnaud Jannin in
Google Scholar
PubMed
Department of Dermatology, Lille University Hospital, Lille, France
Search for other papers by Philippe Jamme in
Google Scholar
PubMed
Search for other papers by Alexandre Fagart in
Google Scholar
PubMed
University of Lille, Lille, France
Search for other papers by Marie-Christine Vantyghem in
Google Scholar
PubMed
Search for other papers by Miriam Ladsous in
Google Scholar
PubMed
was persistently elevated (41 mU/L). Anti-TPO antibodies were positive (265 U/mL ( n < 7)) and anti-thyroglobulin antibodies were negative. Nivolumab was withdrawn 3 months after initiation because of persistent skin toxicity. TSH completely
Search for other papers by P. Reed Larsen in
Google Scholar
PubMed
Search for other papers by Ann Marie Zavacki in
Google Scholar
PubMed
[ 16 ]. This combination allows a decrease in the feedback suppression of TRH and TSH where the latter causes thyroid cell hyperplasia, and increases the sodium iodide symporter, thyroidal D1 and D2, thyroglobulin turnover, and the ratio of T3:T4 in
Search for other papers by Genfeng Yu in
Google Scholar
PubMed
Search for other papers by Siyang Liu in
Google Scholar
PubMed
Search for other papers by Cheng Song in
Google Scholar
PubMed
Search for other papers by Qintao Ma in
Google Scholar
PubMed
Search for other papers by Xingying Chen in
Google Scholar
PubMed
Search for other papers by Yuqi Jiang in
Google Scholar
PubMed
Search for other papers by Hualin Duan in
Google Scholar
PubMed
Search for other papers by Yajun He in
Google Scholar
PubMed
Search for other papers by Dongmei Wang in
Google Scholar
PubMed
Search for other papers by Heng Wan in
Google Scholar
PubMed
Search for other papers by Jie Shen in
Google Scholar
PubMed
), thyroglobulin antibody (TgAb), hemoglobin A1c (HbA1c), creatinine, total cholesterol (TC), and triglycerides (TG) were reported in detail elsewhere ( 33 ). To calculate the estimated glomerular filtration rate (eGFR), the Chronic Kidney Disease Epidemiology